刘发保
|
个人信息Personal Information
教授
性别：男
在职信息：在职
所在单位：高等医学研究院
入职时间：2021-11-15
扫描关注
- [1] . Dual targeting PPARα and NPC1L1 metabolic vulnerabilities blocks tumorigenesis. Cancer letters, 612, 2025.
- [2] . HDAC11 Inhibition as a Potential Therapeutic Strategy for AML: Target Identification, Lead Discovery, Antitumor Potency, and Mechanism Investigation. Journal of Medicinal Chemistry, 2025.
- [3] . Discovery of epigenetic modulators targeting HDACs and EZH2 simultaneously for the treatment of hematological malignancies. Bioorganic Chemistry, 153, 2024.
| 共 3 条 1/1 | 首页上一页下一页尾页 |